AI-Powered Digital Pathology for Real-Time Tissue Image Analysis in Prospective Clinical Trials

This event ran on Thursday April 29, 2021 | 9:00 am PST | 12:00 pm EST

Engager Hosted by

Path AI

The April PathAI Engager will cover:

AI-Powered Digital Pathology for Real-Time Tissue Image Analysis in Prospective Clinical Trials


There has been a growing body of supporting evidence in the translational research field showing the value of digital pathology. The exclusive PathAI Engager will provide leaders in academia, pharma and biotech with the opportunity to explore the benefits of implementing AI-powered digital pathology into clinical trials and understand how it can help better identify the target population and generate additional data to support downstream trial design and hypotheses.

Join this Engager to learn about how PathAI's AI-Powered platform overcomes variability and subjectivity of manual pathology reads and delve into discussions showcasing how patient recruitment and stratification can be more accurate, reproducible and sensitive, leading to more cost-effective trials with robust analysis of crucial endpoints.


  • Learn how to identify and validate new biomarkers from histopathological features that are associated with patient outcomes
  • Discover how PathAI’s AI-Powered platform enables assessment of histopathological features which may be unattainable with manual review
  • Use of PathAI algorithms for quality monitoring in prospective clinical trials by identifying sources of variability from sample preparation source, staining system used (including drifts over time) and pathologist interpretation
  • Use of AI-based biomarkers for more accurate, precise and faster patient enrolment, patient stratification and patient response to therapy measurement using histological endpoints


Delve deep into the advantages of applying AI-power digital pathology in prospective clinical trials by virtually joining C-Level leaders, VPs, Directors and Heads from precision medicine, translational medicine and clinical drug development departments.



Path AI

PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning. Based in Boston, PathAI works with leading life sciences companies and researchers to advance precision medicine.